Euda Health Holdings Stock EBITDA
EUDA Stock | 4.43 0.11 2.55% |
EUDA Health Holdings fundamentals help investors to digest information that contributes to EUDA Health's financial success or failures. It also enables traders to predict the movement of EUDA Stock. The fundamental analysis module provides a way to measure EUDA Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EUDA Health stock.
Last Reported | Projected for Next Year | ||
EBITDA | -8.3 M | -8.7 M |
EUDA | EBITDA |
EUDA Health Holdings Company EBITDA Analysis
EUDA Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current EUDA Health EBITDA | (8.3 M) |
Most of EUDA Health's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EUDA Health Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
EUDA EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for EUDA Health is extremely important. It helps to project a fair market value of EUDA Stock properly, considering its historical fundamentals such as EBITDA. Since EUDA Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of EUDA Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of EUDA Health's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition |
EUDA Ebitda
Ebitda |
|
According to the company disclosure, EUDA Health Holdings reported earnings before interest,tax, depreciation and amortization of (8.3 Million). This is 100.95% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The ebitda for all United States stocks is 100.21% higher than that of the company.
EUDA EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EUDA Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EUDA Health could also be used in its relative valuation, which is a method of valuing EUDA Health by comparing valuation metrics of similar companies.EUDA Health is currently under evaluation in ebitda category among its peers.
EUDA Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, EUDA Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to EUDA Health's managers, analysts, and investors.Environmental | Governance | Social |
EUDA Health Institutional Holders
Institutional Holdings refers to the ownership stake in EUDA Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of EUDA Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing EUDA Health's value.Shares | Hudson Bay Capital Management Lp | 2024-09-30 | 800 K | Citadel Advisors Llc | 2024-09-30 | 33.8 K | Walleye Trading Advisors, Llc | 2024-06-30 | 16.6 K | Geode Capital Management, Llc | 2024-09-30 | 16 K | Ubs Group Ag | 2024-06-30 | 10.6 K | Yakira Capital Management, Inc. | 2024-06-30 | 0.0 | Renaissance Technologies Corp | 2024-06-30 | 0.0 | Wolverine Asset Management Llc | 2024-06-30 | 0.0 | Xtx Topco Ltd | 2024-06-30 | 0.0 |
EUDA Fundamentals
Return On Asset | -0.86 | ||||
Operating Margin | (0.83) % | ||||
Current Valuation | 162.88 M | ||||
Shares Outstanding | 37.15 M | ||||
Shares Owned By Insiders | 49.35 % | ||||
Shares Owned By Institutions | 2.47 % | ||||
Number Of Shares Shorted | 4.92 K | ||||
Price To Sales | 42.11 X | ||||
Revenue | 3.71 M | ||||
Gross Profit | 3.35 M | ||||
EBITDA | (8.3 M) | ||||
Net Income | (8.44 M) | ||||
Total Debt | 3.37 M | ||||
Book Value Per Share | (0.17) X | ||||
Cash Flow From Operations | (2.92 M) | ||||
Short Ratio | 0.07 X | ||||
Earnings Per Share | (0.62) X | ||||
Target Price | 6.0 | ||||
Number Of Employees | 106 | ||||
Beta | -0.004 | ||||
Market Capitalization | 160.5 M | ||||
Total Asset | 1.31 M | ||||
Retained Earnings | (34.74 M) | ||||
Working Capital | (7.99 M) | ||||
Net Asset | 1.31 M |
About EUDA Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EUDA Health Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EUDA Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EUDA Health Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether EUDA Health Holdings is a strong investment it is important to analyze EUDA Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact EUDA Health's future performance. For an informed investment choice regarding EUDA Stock, refer to the following important reports:Check out EUDA Health Piotroski F Score and EUDA Health Altman Z Score analysis. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EUDA Health. If investors know EUDA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EUDA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Revenue Per Share 0.144 | Quarterly Revenue Growth (0.14) | Return On Assets (0.86) |
The market value of EUDA Health Holdings is measured differently than its book value, which is the value of EUDA that is recorded on the company's balance sheet. Investors also form their own opinion of EUDA Health's value that differs from its market value or its book value, called intrinsic value, which is EUDA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EUDA Health's market value can be influenced by many factors that don't directly affect EUDA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EUDA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if EUDA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EUDA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.